|Bid||1.3300 x 38800|
|Ask||1.3600 x 39400|
|Day's range||1.2100 - 1.3800|
|52-week range||1.1650 - 4.9100|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||01 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.59|
Ginkgo is teaming up with Synlogic to launch a new gout drug, moving shares of both stocks higher.
Today we will run through one way of estimating the intrinsic value of Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA ) by...
A look at the shareholders of Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA ) can tell us which group is most powerful...